Alimta IV Injection 500 mg/20 ml contains Pemetrexed, a chemotherapy medication used in the treatment of certain types of cancer. It belongs to a class of drugs known as antifolate antineoplastic agents, which work by interfering with the growth and multiplication of cancer cells. This medication is widely used in oncology to treat cancers such as Non‑Small Cell Lung Cancer and Malignant Pleural Mesothelioma.

Alimta is administered intravenously (IV) under the supervision of qualified healthcare professionals, typically in a hospital or oncology treatment center. It may be used alone or in combination with other chemotherapy agents depending on the type and stage of cancer.রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition and Mechanism of Action

The active ingredient in Alimta Injection is Pemetrexed, which works by disrupting essential metabolic processes required for cancer cell survival. Pemetrexed inhibits several key enzymes involved in folate-dependent metabolic pathways, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. These enzymes are necessary for the synthesis of DNA and RNA, which are vital for cell division.

By blocking these enzymes, Pemetrexed prevents cancer cells from producing the building blocks needed for replication, ultimately leading to inhibition of tumor growth and cancer cell death. Because cancer cells divide rapidly, they are particularly sensitive to this mechanism.

Indications

Alimta IV Injection is primarily indicated for the treatment of certain cancers, including:

• Treatment of Non‑Small Cell Lung Cancer, either as first-line therapy in combination with other chemotherapy drugs or as maintenance therapy

• Treatment of Malignant Pleural Mesothelioma, often combined with cisplatin

• Maintenance therapy for patients with advanced lung cancer whose disease has not progressed after initial chemotherapy

• Certain cases of recurrent or advanced cancers as recommended by oncologists

Dosage and Administration

Alimta Injection is administered intravenously over about 10 minutes by a trained healthcare professional. The dosage depends on factors such as the patient’s body surface area, type of cancer, stage of disease, and overall health condition.

Patients receiving Pemetrexed therapy are often advised to take folic acid and vitamin B12 supplements before and during treatment to reduce the risk of certain side effects. Doctors may also prescribe corticosteroids to minimize skin reactions.

The treatment is usually given in cycles, often every three weeks, allowing the body time to recover between doses.

Benefits

Alimta IV Injection provides several important therapeutic benefits:

• Effective treatment option for advanced lung cancer and mesothelioma

• Can be used in combination therapy or maintenance therapy

• Helps slow tumor growth and progression

• May improve survival outcomes in certain patients

• Well-established chemotherapy agent in modern oncology practice

Possible Side Effects

Like most chemotherapy medications, Alimta Injection may cause side effects. Common side effects include:

• Fatigue and weakness

• Nausea and vomiting

• Loss of appetite

• Low blood cell counts

• Mouth sores

• Skin rash

More serious side effects can include severe infection, anemia, kidney problems, or breathing difficulties. Patients undergoing treatment are closely monitored with regular blood tests and medical assessments.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

Before receiving Alimta Injection, patients should inform their doctor if they have:

• Kidney disease

• Liver problems

• Previous chemotherapy or radiation therapy

• Active infections or weakened immune system

Special care is required when the drug is used with other chemotherapy medications such as Cisplatin, as this may increase the intensity of side effects. Pregnant or breastfeeding women should avoid this medication unless clearly recommended by a doctor.

Storage

Alimta Injection should be stored according to manufacturer instructions, usually in a cool, dry place and protected from light. Preparation and dilution of the injection should be performed only by trained medical professionals under sterile conditions.